[go: up one dir, main page]

GB2085729B - Pharmaceutical composition for oral administration containing coagulation factor viii - Google Patents

Pharmaceutical composition for oral administration containing coagulation factor viii

Info

Publication number
GB2085729B
GB2085729B GB8130122A GB8130122A GB2085729B GB 2085729 B GB2085729 B GB 2085729B GB 8130122 A GB8130122 A GB 8130122A GB 8130122 A GB8130122 A GB 8130122A GB 2085729 B GB2085729 B GB 2085729B
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
oral administration
factor viii
coagulation factor
administration containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8130122A
Other versions
GB2085729A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma Co Ltd
Original Assignee
Dainippon Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co Ltd filed Critical Dainippon Pharmaceutical Co Ltd
Publication of GB2085729A publication Critical patent/GB2085729A/en
Application granted granted Critical
Publication of GB2085729B publication Critical patent/GB2085729B/en
Expired legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nanotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GB8130122A 1980-10-17 1981-10-06 Pharmaceutical composition for oral administration containing coagulation factor viii Expired GB2085729B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP55144508A JPS5770814A (en) 1980-10-17 1980-10-17 Oral preparation of blood clotting eighth factor

Publications (2)

Publication Number Publication Date
GB2085729A GB2085729A (en) 1982-05-06
GB2085729B true GB2085729B (en) 1984-04-18

Family

ID=15363986

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8130122A Expired GB2085729B (en) 1980-10-17 1981-10-06 Pharmaceutical composition for oral administration containing coagulation factor viii

Country Status (5)

Country Link
JP (1) JPS5770814A (en)
DE (1) DE3141223A1 (en)
ES (1) ES8306323A1 (en)
FR (1) FR2492260A1 (en)
GB (1) GB2085729B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586573B1 (en) 1999-02-22 2003-07-01 Baxter International Inc. Albumin-free Factor VIII formulations

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536392A (en) * 1983-06-27 1985-08-20 Queen's University At Kingston Method for controlling hemophilia in mammals
IT1164363B (en) * 1983-08-03 1987-04-08 Foscama Biomed Chim Farma THERAPEUTIC PROCEDURE FOR THE USE OF EMBORNED LIPOSOMES FRUCTOSE 1.6 DIPHOSPHATE AND PROCEDURE FOR THE PREPARATION OF THE SAME
JPS6150912A (en) * 1984-08-16 1986-03-13 Shionogi & Co Ltd Production of liposome preparation
FR2581543B1 (en) * 1985-05-09 1989-07-07 Tressens Dominique PHARMACOTECHNIE ALLOWING THE PRODUCTION OF AN ORAL ACTIVE INSULIN PREPARATION
DE3625090A1 (en) * 1986-07-24 1988-01-28 Behringwerke Ag AGENT FOR THE THERAPY FACTOR VIII-RESISTANT HAEMOPHILY A AND METHOD FOR THE PRODUCTION THEREOF
GB8822857D0 (en) * 1988-09-29 1988-11-02 Patralan Ltd Pharmaceutical formulations
GB9007052D0 (en) * 1990-03-29 1990-05-30 Skua Investments Ltd Pharmaceutical formulations
DE4115453A1 (en) * 1991-05-11 1992-11-12 Knoll Ag NEW ACTIVE COMPOUND
WO1994028876A1 (en) * 1993-06-07 1994-12-22 Advanced Therapies, Inc. Liposome powders
FR2706302B1 (en) * 1993-06-18 1995-08-18 Franche Comte Universite Basifying product in gastro-resistant form.
US6017891A (en) * 1994-05-06 2000-01-25 Baxter Aktiengesellschaft Stable preparation for the treatment of blood coagulation disorders
DE4416180C2 (en) * 1994-05-06 1997-08-14 Immuno Ag Stable preparation for the treatment of blood coagulation disorders and method for producing this preparation
DE4416166C2 (en) * 1994-05-06 1997-11-20 Immuno Ag Stable preparation for the treatment of blood clotting disorders
CH689139A5 (en) * 1995-04-03 1998-10-30 Cerbios Pharma Sa Process for the preparation of a liposomal, in water dispersable, orally administrable, solid, dry therapeutic formulation.
AU9221698A (en) * 1997-09-04 1999-03-22 Biozone Laboratories, Inc. Oral liposomal delivery system
BRPI0921429B1 (en) 2008-11-07 2022-07-12 Takeda Pharmaceutical Company Limited STABLE LYOPHILIZED PHARMACEUTICAL FORMULATION, AND METHOD FOR PREPARING A STABLE LYOPHILIZED FACTOR
DE102009001334B4 (en) 2009-03-04 2017-02-23 Stefan Brosig Simple enteric encapsulation, e.g. of ginger and other delicate substances
CN109316599A (en) * 2018-08-24 2019-02-12 上海交通大学医学院附属瑞金医院 Application of aprotinin or mutant, derivative, analogue or constituent fragment thereof
CN116793783A (en) * 2023-05-26 2023-09-22 司法鉴定科学研究院 Capsule type drug-containing biological matrix freeze-drying reagent and preparation method and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2249552A1 (en) * 1971-10-12 1973-05-30 Inchema S A PROCESS FOR THE INCAPSULATION OF IN PARTICULAR WATER-SOLUBLE COMPOUNDS
NL7900459A (en) * 1979-01-19 1980-07-22 Hendrik Coenraad Hemker Prof D PHARMACEUTICAL PREPARATION AND METHOD OF PREPARATION THEREOF.

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586573B1 (en) 1999-02-22 2003-07-01 Baxter International Inc. Albumin-free Factor VIII formulations
US7087723B2 (en) 1999-02-22 2006-08-08 Baxter International Inc. Albumin-free factor VIII formulations
US7247707B2 (en) 1999-02-22 2007-07-24 Baxter International Inc. Albumin-free factor VIII formulations
US8058226B2 (en) 1999-02-22 2011-11-15 Baxter International Inc. Albumin-free factor VIII formulations

Also Published As

Publication number Publication date
DE3141223A1 (en) 1982-06-24
ES506320A0 (en) 1983-05-16
FR2492260B1 (en) 1984-07-27
JPS5770814A (en) 1982-05-01
JPH03366B2 (en) 1991-01-07
GB2085729A (en) 1982-05-06
ES8306323A1 (en) 1983-05-16
FR2492260A1 (en) 1982-04-23

Similar Documents

Publication Publication Date Title
IL63036A (en) Dosage units for oral administration
GB2085729B (en) Pharmaceutical composition for oral administration containing coagulation factor viii
DE3476633D1 (en) Powdery pharmaceutical composition for nasal administration
IL82911A (en) Pharmaceutical composition comprising omeprazole for oral use
EP0202051A3 (en) Therapeutic compositions for oral administration
IL71967A (en) Drug administration composition
DK163959C (en) PHARMACEUTICAL PREPARATION FOR ORAL ADMINISTRATION CONTAINING CIMETIDIN
MY8600029A (en) 2-hydroxy-5-phenylazobenzoic acid derivatives and pharmaceutical compositions containing themn
ZA813465B (en) Pharmaceutical composition
DE3367849D1 (en) Pharmaceutical compositions containing n-substituted-3-hydroxypyrid-2-one or -4-one derivatives
GB8319407D0 (en) Medicinal composition containing pirprofen
CY1574A (en) Pharmaceutical compositions containing 1-hydroxypyramid-2-one derivatives
IL62200A (en) Piperidine derivatives,their preparation and pharmaceutical compositions containing them
PH22726A (en) Pharmaceutical composition containing oxicam derivatives
IL95158A0 (en) Pharmaceutical composition for oral administration containing n-acetyl-cysteine
GB2088373B (en) Dibenzazepine derivatives and pharmaceutical compositions containing them
GB2074445B (en) Oral pharmaceutical compositions containing cytidine diphospholine
ZA82361B (en) Pharmaceutical composition for treating diseases of the oral cavity
ZA812034B (en) Phrimidyl-quinazolines,process for their preparation pharmaceutical formulations containing these compounds,and their use
ZA817787B (en) Indolinone derivatives,processes for their preparation and pharmaceutical compositions containing these
IL87494A0 (en) Pharmaceutical compositions containing benzylpyrimidine derivatives
GB2052980B (en) Pharmaceutical composition for oral administration comprising methoxsalen
ATA409082A (en) Oral pharmaceutical composition containing FK506
DE3163490D1 (en) 1,2,4-triazinylthiomethyl-3-cephem sulfoxides, process for their preparation and pharmaceutical compositions containing them
JPS57206615A (en) Medicinal composition containing guanfasin

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee